Test Price
2,800 AED✅ Home Collection Available
CSRP3 Gene Familial Hypertrophic Cardiomyopathy Type 12 Genetic Test in UAE – 2800 AED – DHA Licensed Molecular Diagnostics
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- ✓ Clinical Guidance: Telephonic post-test clinical guidance for result interpretation with a DHA-licensed genetics expert.
- ✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- ✓ Core Metric: 3–4 week turnaround including comprehensive clinical reporting by DHA-licensed Consultant Medical Geneticist.
Test Overview & Methodology
The CSRP3 NGS test detects pathogenic variants in the CSRP3 gene, the primary cause of Familial Hypertrophic Cardiomyopathy Type 12 (FHC12). This comprehensive genetic analysis employs next-generation sequencing (Illumina platform) covering all coding regions and splice sites, paired with Sanger confirmation for clinically significant findings. Results are interpreted alongside echocardiogram, ECG, and family history to empower proactive cardiac risk management in the UAE.
Diagnostic Capability Comparison
| Feature | Our CSRP3 NGS Test (UAE) | Closest Alternative |
|---|---|---|
| Precision | >99.9% analytical sensitivity, covering all coding regions & splice sites via full-gene NGS | Targeted genotyping (common variants only) – may miss rare or novel mutations |
| Method | Next-Generation Sequencing (Illumina platform) with Sanger confirmation | PCR-based fragment analysis; lower resolution for novel variant detection |
| Speed | Results in 3–4 weeks including clinical report by DHA-certified geneticist | Often 6–8 weeks with external referral or send-out laboratory |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist practicing in Dubai, I emphasize that a genetic finding from this CSRP3 analysis represents one piece of a comprehensive cardiac evaluation. Patients must integrate these results with echocardiographic data, Holter monitoring, and a detailed three-generation family pedigree. Collaborative decision-making with a treating cardiologist remains essential for optimal clinical outcomes.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
⚠️ Important Clinical Note
Do not discontinue, alter, or adjust any prescribed cardiac medication—including beta-blockers, calcium channel blockers, or antiarrhythmics—without direct consultation with your treating cardiologist. This genetic test is designed to inform long-term risk stratification, not to guide acute pharmacologic changes.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who have undergone heart transplantation or are on chronic immunosuppressive therapy must inform the laboratory prior to sample collection; alternative testing strategies may apply.
- Red Flag: New or worsening chest pain, severe shortness of breath, syncope, or palpitations warrant immediate emergency care. This genetic test is not a substitute for acute medical evaluation.
- Red Flag: Do not delay urgent cardiology consultation while awaiting genetic results; clinical management and surveillance should continue uninterrupted.
Patient FAQ & Clinical Guidance
1. What is the CSRP3 Gene Familial Hypertrophic Cardiomyopathy Type 12 test?
This advanced genetic test screens for pathogenic mutations in the CSRP3 gene, which causes Familial Hypertrophic Cardiomyopathy Type 12 (FHC12), a hereditary heart muscle disorder characterised by abnormal thickening of the left ventricle. Early detection through genetic analysis enables proactive cardiac surveillance and family-wide risk assessment.
2. How should I prepare for sample collection?
No fasting or special preparation is required. A peripheral whole blood sample will be collected by our DHA-licensed phlebotomist during a scheduled home visit. A brief pre-test genetic counselling session is included to document your personal and family cardiac history.
3. What does a positive result mean for my family?
A positive finding indicates an elevated risk for developing hypertrophic cardiomyopathy. Cascade testing of first-degree relatives (parents, siblings, children) is strongly recommended. Our clinical team provides post-test counselling to guide preventive cardiology follow-up and surveillance imaging schedules.
4. Will insurance cover this genetic test?
We offer direct billing verification for most UAE health insurance plans. Contact our team via WhatsApp at +971 54 548 8731 to check your specific coverage and obtain a pre-authorisation estimate before scheduling the collection.
UAE Regulatory & Data Privacy Adherence
Data Protection Framework: All genetic data is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient confidentiality, data encryption, and access control measures exceed regulatory standards to safeguard your genetic information.
Clinical Safety & Consent: All procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent, transparent result disclosure, and the highest standard of clinical governance throughout the testing pathway.
Clinical & Logistical Metadata
| Test Name | CSRP3 Gene Familial Hypertrophic Cardiomyopathy Type 12 (FHC12) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL EDTA tube) or FTA card dried blood spot |
| Methodology Used | Next-Generation Sequencing (Illumina platform) with Sanger confirmation for clinically significant variants |
| ICD-10-CM Code | I42.2 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians